Background: There is a growing interest in transdermal delivery systems because of their noninvasive, targeted, and on-demand delivery of gene and drugs.
INTRODUCTION
Transdermal delivery is described as delivery of therapeutic compounds across the skin layer [1, 2] . The large surface area of the human skin tissue offers a convenient, selective, and noninvasive route for gene and drug delivery [3] . Transdermal administration of gene and drug not only can be used for the skin specific maladies but also could be applied for systemic therapeutic delivery and vaccination [4] . Furthermore, transdermal delivery overcomes the first-pass hepatic metabolism and can reduce harmful side effects that are found in oral, nasal, and/or intravenous administrations [1, 2] . Additionally, transdermal delivery devices are simply accessible, replaceable, controllable, and could be selfadministered in several cases [1, 5, 6] . Despite several advantages of transdermal gene and drug delivery systems, efficient transdermal delivery of pharmacological agents is still challenging largely due to the impermeability of the outermost layer of the skin called stratum corneum (SC) [7] . This issue is even more severe in the case of drugs with large molecular weight and hydrophilic properties [8, 9] .
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In order to increase the skin penetration of therapeutic agents and boost the efficiency of transdermal delivery systems, pharmaceutical scientists have come up with various methods to enhance the permeability of the skin barrier. Some of these methods rely on the physical disturbance of the SC layer (e.g. using microneedles (MNs) [10] or electroporation [11] ) whereas some others deal with chemical modifications of therapeutic agents or the SC layer for enhanced skin penetration [7, 12, 13] . Hair follicles have also been explored as another transport channel for transdermal delivery of gene and drugs [14, 15] . This paper aims to review recent advances in the skin penetration enhancers for transdermal gene and drug delivery applications. The paper is organized as follows: first, the multilayered structure of the skin is described. Herein, we show that the SC layer is the main skin barrier for efficient transdermal gene and drug delivery. Second, physical routes for transdermal delivery enhancement are detailed. Third, we explain different gene and drug nanocarriers for enhanced transdermal delivery. Fourth, we show that cell-penetrating peptides (CPPs) can assist therapeutic compounds or carriers to penetrate into the skin. Fifth, we summarize recent progress of using hair follicles as transdermal delivery channels followed by some important clinical applications of transdermal gene and drug delivery systems. Last section provides our conclusions on skin penetration enhancers.
MULTILAYERED STRUCTURE OF THE SKIN
The multilayered structure of the skin is illustrated in (Fig. 1) . The human skin is mainly composed of epidermis, dermis, and hypodermis layers [1, 2, 16] . The epidermis layer is in direct contact with the environment and controls the water release rate of the body. The dermis layer is comprised of dense irregular connective tissue and maintains sensors (e.g. mechanoreceptors and thermoreceptors) and blood vessels. Furthermore, the hypodermis layer is the deepest layer of the skin and serves as skin energy supplier. The 10-20 µm thick outermost layer of the skin, SC, is known as the main barrier for transdermal gene and drug delivery because of its extracellular structure [2, 16] . To overcome this barrier, there have been significant efforts to physically or chemically enhance the permeability of the SC layer for efficient gene and drug delivery [1, 13, 16] . On the other hand, nanoscale delivery systems capable of passing the intercellular or follicular routes have actively been studied as an alternative or complementary strategy to promote the transdermal delivery efficiency [17, 18] .
SKIN PENETRATION ENHANCERS
As mentioned in the introduction section, numerous strategies have been explored to enhance the skin penetration of therapeutic agents. In this section, we summarize some representative examples of various physical and nonphysical enhancers for transdermal gene and drug delivery:
Physical Routes
There are several physical methods to enhance the transdermal gene and drug delivery [7, 12] . These methods are mostly based on the ablation of the SC layer or application of an external force to facilitate the drug penetration [19] . Fig.  2a depicts the most important physical routes have been in-vestigated for enhancement of the drug penetration into the skin. Most of these physical methods including ultrasound, electroporation, and MNs are applicable to transdermal gene delivery as well.
External physical forces can be used to increase the drug penetration depth by forming a temporary change in the structure of the SC layer or enhancing the diffusion rate of drug molecules [20] . To date, different sources have been employed to apply external physical forces to the SC layer [21] . For example, ultrasonic waves can enhance the transdermal drug penetration by means of different underlying mechanisms ( Fig. 2b) [22, 23] . Thermal effect and cavitation are the main consequences of using ultrasound waves that can facilitate the drug penetration. Upon ultrasound treatment of the skin, it partially absorbs the energy from ultrasonic waves, leading to a local increase in the skin temperature which in turn significantly enhances the diffusivity of the skin toward drug molecules [24] . A significant enhancement (35 times) in the permeation of mannitol as a model drug has been observed when 20 kHz ultrasound waves were applied to the skin. The enhanced drug penetration was postulated to be the increase of the skin temperature. However, it was found that increasing the skin temperature without using ultrasound could also enhance the drug penetration, but not as high as that of the ultrasound-treated skin. This finding have suggested that there should be other mechanisms that cooperate with raised temperature in order to boost the drug permeation [25] . Studies have shown that another assisting mechanism is formation of micro-gaseous cavities which could be created in the biological medium (e.g. skin layers) upon acoustic pressure cycles. These types of microcavities cause shear force over skin cell layers through two mechanisms as microstreaming and inertial cavitation. The "microstreamings" can be originated from the unidirectional flow of fluid due to the movement of bubbles under the ef- Fig. (1) . Schematic illustration of the skin at a cross-section. The skin is composed of epidermis, hypodermis, and dermis containing blood vessels (1), lymph vessels (2), nerve endings (3), mechanoreceptors (4), hair follicles (5) , and sweat glands (6) . Reproduced with permission from ref. [1] Copyright 2012 Royal Society of Chemistry. fect of ultrasonic waves and inertial cavitation can be produced due to sudden growth and collapse of microbubbles ( Fig. 2b) [22, 26, 27] .
Although low-frequency ultrasound is being studied for its application in transdermal drug delivery as well as other medical applications, there still are many open questions for safety issues of this method. The biggest efforts are toward minimizing the side effects associated with skin temperature change and cavitation during ultrasonic treatments [28, 29] .
Another well-studied source of external force for the enhancement of drug permeation is laser ( Fig. 2c) [30, 31] . Application of laser can lead to the ablation of the SC layer as well as increase of the skin diffusivity due to temperature increase. Both scenarios can result in increasing the drug permeation depth. Different types of laser (CO 2 , Nd:YAG, Erb:YAG, etc.) have been employed for drug delivery applications. Particularly, commercial products are already available in the market for delivery of macromolecular drugs and vaccination [32, 33] . Additionally, laser technology has been investigated for increasing the permeability of oligonucleotides for vaccination purposes. Furthermore, this technology has been used for transdermal administration of both DNA and RNA based vaccines [34, 35] .
Another common permeation assistant strategy is the use of electroporation [36] [37] [38] [39] . Electroporation employs a pair of electrodes than can be attached to the skin (Fig. 2d) . When an electric filed is applied to electrodes, the energy needed for water molecules to enter the cells is reduced, due to the rearrangement of the molecular structure in the cell membrane. Subsequently, a higher number of pores can be formed on the cell membrane due to excess entrance of water, leading to an increase of the cell permeability [40] . Although the biophysical concept is complex, this enhancement method has been exploited thoroughly over the last decades to increase the penetration through cell membranes or biological barriers including the skin [41, 42] .
With respect to transdermal drug delivery, it has been shown that electroporation can create an aqueous pathway through the SC layer, thereby leading to an increase of the skin permeability. This method can be used for different types of therapeutic molecules with different size and surface characteristics (e.g. low/high molecular weight, hydrophilic or lipophilic, proteins or oligonucleotides). The main drawback of this method, however, is its low reproducibility. Additionally, this method should be utilized with extreme caution due to the application of high voltage pulses. When the voltage or application time exceed certain limits, skin irritation or damage, edema, and muscle contraction can occur [43] [44] [45] [46] .
Bypassing the SC layer of the skin could be performed by MN arrays (Fig. 2e) [10, [47] [48] [49] [50] [51] . MNs fabricated on a substrate or patch support can piece the epidermis layer and form microchannels for efficient gene and drug delivery. Therapeutic drug or (oligo)nucleotides could be administrated using MN patches [50] . MNs can be hollow and com- pletely solid structure. Hollow MNs direct the therapeutic drug from a reservoir through the skin layer. In the case of solid MNs, the drug loaded in MNs can often be released upon continuous biodegradation of MN materials in a controlled rate (Fig. 2f) [10] . This platform is straight forward for transdermal gene and drug delivery due to its painless, noninvasive, and controlled delivery profile. Besides transdermal delivery of MN patches, they can potentially function as biosensing devices for feedback controlled gene and drug delivery [51, 52] .
Gene and Drug Carriers
Numerous drugs have inefficient permeation rate into the skin. To enhance the gene or drug permeation across the skin, one approach is to encapsulate or condense the therapeutic compounds or (oligo)nucleotide inside nano-scale carriers with proper surface chemistry [16, [53] [54] [55] [56] [57] [58] . These types of nanocarriers not only increase the penetration efficiency but also protect the gene or drug during the administration process and consequently reduce the immunogenicity [59] . Moreover, nanocarriers with tunable degradation properties can add another layer of control to the drug release rate. Different nanocarrier systems have been employed for transdermal gene and drug delivery including carbon nanotubes, liposomes, chitosan tripolyphosphate (CS/TPP) (pDNA), peptides, and dendrimers for the delivery of different (oligo)nucleotides such as pDNA and siRNA [59] [60] [61] [62] [63] . Notably, liposomal systems are among the most common carriers for transdermal gene delivery.
Liposomal systems are also very popular for transdermal drug delivery [64, 65] . Fig. 3a shows a representative example of a transdermal drug delivery system using liposomal carriers [66] . As schematically depicted in the figure, free curcumin nanoparticles cannot penetrate into the deep layers of skin due to the impermeability of the SC layer. Encapsulating curcumin in nano-metric liposomes, however, increased the permeation due to lipophilic feature of liposomes. Moreover, incorporation of carbon-dots in the liposome structure improved their stability and permeability. It has been shown that functionalization of liposome with a CPP can further increase the skin permeation depth [66] . We have detailed the application of CPPs in the next section.
CPPs
CPPs are certain peptides on the surface of some pathogens that can help pathogens penetrate into the cells and colonize them. These peptides have been extensively studied regarding their role in emerging of infections. The discovery of CPPs was studied with TAT, a transactivating factor belonging to HIV virus. Since then, such peptides have been recognized for transdermal delivery. They are generally short peptides consisting of less than 40 amino acids and can recruit different mechanisms to internalize into the cells. CPP family mainly includes TAT, penetratin, and polyarginine [67, 68] .
In drug delivery, these peptides have been isolated and attached to drugs or drug carriers in order to give them the cell penetrating feature and increase their therapeutic efficiency [69] . In addition, they have been used to increase the transfection efficiency in gene delivery applications. Diverse types of CPPs have been attached to different types of (oligo)nucleotide or gene carriers in order to increase their competence to internalize into the cells. Although CPPs have been studied extensively, the mechanism behind their role in cell internalization is not fully understood yet. We suggest the reader the review from Boisguérin et al. for a full discussion on the application of CPPs in gene delivery [70] . CPPs have been used also in combination with the recently discovered gene delivery systems such as Transcription activatorlike effector nucleases (TALENs) [71] and CRISPR/Cas9 system for the purpose of gnome editing [72] .
It has been shown that liposomes attached to an arginine rich CPP have better permeability and subsequently drug delivery efficiency in a transdermal drug delivery experiment [70] . This type of CPP can even increase the skin permeation of naked drugs. In a recent study, a novel type of CPPs (IMT-P8) was conjugated to KLA (a pro-apoptotic peptide). The KLA peptide conjugated with CPP had a significantly higher skin permeation (Fig. 3b) [73] . Also, it was shown that CPPs can increase the transdermal permeation rate of oligonucleotides. For example, TAT was conjugated to gold/PEI particles to enhance the transdermal gene delivery for a topical application [74] . In recent years, another group of peptides (SPACE peptides) has been discovered through phage display, which is getting increasing interest due to its skin penetration competence. SPACE peptides have successfully been used for transdermal drug delivery, as well as transdermal oligonucleotide delivery [75, 76] . In addition to different nanocarriers discussed here, biohybrid nanosystems could also be utilized for transdermal delivery and enhancement of the therapeutic penetration depth [77] [78] [79] .
Hair Follicles
As discussed above, the SC layer of the skin is a very strong barrier for any external material including therapeutic drugs. However, it has been shown that certain drugs can pass through hair follicles in a more efficient way. Although this is not a real enhancer, hair follicles can be recognized as a strategy to increase the drug permeation efficiency [14, [80] [81] [82] . In fact, hair follicles themselves could be targeted for treatment of certain hair and skin disorders [83] . The other aspect making hair follicles even more interesting is the presence of certain cells like immune cells. These cells can be used as a target for transdermal vaccination [82] . Additionally, blood vessels and stem cells near hair follicles can be other destinations for therapeutic genes and drugs [81] .
APPLICATIONS
The main goals in drug delivery research are to make the drug administration more comfortable for patients, control the administrated doses, and guide the drugs to the site of disease in order to increase the therapeutic efficiency and reduce the side effects. Considering these facts, transdermal drug delivery can bring the opportunity to administrate multiple doses of drugs with precise control in a noninvasive and painless manner. Besides that, there are certain skin problems which could rather be reached through transdermal drug delivery, much easier than the systemic administration of drugs. Some common applications of transdermal drug delivery systems are indicated in Fig. 4 [84] [85] [86] [87] [88] . For example, smoking-quitting patches [84] , insulin delivery [89] , delivery of parathyroid hormone (PTH) for treatment of osteoporosis [90] , and vaccination [91] are among the important applications of transdermal delivery.
CONCLUSION
Gene therapy is considered as one of the most promising therapeutic routes. Different methods have been developed for transferring the (oligo)nucleotides to the site of disease. In this paper, we reviewed some representative examples of skin penetration enhancers for efficient transdermal gene and drug delivery. Physical and chemical routes, together with functional nanocarriers and hair follicles have been proposed to improve the skin penetration of therapeutic compounds. Among these methods, MN patches are getting more attention for transdermal gene and drug delivery due to their painless procedure, controlled release, and capability of delivering various drugs.
